# Alphabet Inc.: financial statements, quarterly

GOOGL · Nasdaq · CIK 1652044 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/googl.md) · [Financials](/companies/googl/financials.md) · [Filings](/companies/googl/filings.md) · [Insiders](/companies/googl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/googl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [86.3 d](/filings/0001652044-25-000014.md) | [80.5](/filings/0001652044-25-000043.md) | [84.7](/filings/0001652044-24-000079.md) | [88.3](/filings/0001652044-24-000118.md) | [96.5 d](/filings/0001652044-25-000014.md) | [90.2](/filings/0001652044-25-000043.md) | [96.4](/filings/0001652044-26-000071.md) | [102](/filings/0001652044-26-000084.md) | [114 d](/filings/0001652044-26-000018.md) | [110](/filings/0001652044-26-000048.md) | [120](/filings/0001652044-26-000071.md) | [128](/filings/0001652044-26-000084.md) |
| Cost of revenue | $bn | [37.6 d](/filings/0001652044-26-000018.md) | [33.7](/filings/0001652044-25-000043.md) | [35.5](/filings/0001652044-25-000062.md) | [36.5](/filings/0001652044-25-000091.md) | [40.6 d](/filings/0001652044-26-000018.md) | [36.4](/filings/0001652044-26-000048.md) | [39.0](/filings/0001652044-26-000071.md) | [41.4](/filings/0001652044-26-000084.md) | [45.8 d](/filings/0001652044-26-000018.md) | [41.3](/filings/0001652044-26-000048.md) | [45.9](/filings/0001652044-26-000071.md) | [51.4](/filings/0001652044-26-000084.md) |
| Research and development | $bn | [12.1 d](/filings/0001652044-26-000018.md) | [11.9](/filings/0001652044-25-000043.md) | [11.9](/filings/0001652044-25-000062.md) | [12.4](/filings/0001652044-25-000091.md) | [13.1 d](/filings/0001652044-26-000018.md) | [13.6](/filings/0001652044-26-000048.md) | [13.8](/filings/0001652044-26-000071.md) | [15.2](/filings/0001652044-26-000084.md) | [18.6 d](/filings/0001652044-26-000018.md) | [17.0](/filings/0001652044-26-000048.md) | [18.2](/filings/0001652044-26-000071.md) | [20.6](/filings/0001652044-26-000084.md) |
| Operating income | $bn | [23.7 d](/filings/0001652044-26-000018.md) | [25.5](/filings/0001652044-25-000043.md) | [27.4](/filings/0001652044-25-000062.md) | [28.5](/filings/0001652044-25-000091.md) | [31.0 d](/filings/0001652044-26-000018.md) | [30.6](/filings/0001652044-26-000048.md) | [31.3](/filings/0001652044-26-000071.md) | [31.2](/filings/0001652044-26-000084.md) | [35.9 d](/filings/0001652044-26-000018.md) | [39.7](/filings/0001652044-26-000048.md) | [40.8](/filings/0001652044-26-000071.md) | [40.6](/filings/0001652044-26-000084.md) |
| Interest expense | $bn | [0.1 d](/filings/0001652044-24-000022.md) | [0.1](/filings/0001652044-24-000053.md) | [0.1](/filings/0001652044-25-000062.md) | [0.1](/filings/0001652044-25-000091.md) | [0.1 d](/filings/0001652044-26-000018.md) | [0.0](/filings/0001652044-26-000048.md) | [0.3](/filings/0001652044-26-000071.md) | [0.1](/filings/0001652044-26-000084.md) | [0.3 d](/filings/0001652044-26-000018.md) | [0.5](/filings/0001652044-26-000048.md) | [1.3](/filings/0001652044-26-000071.md) | [1.0](/filings/0001652044-26-000084.md) |
| Income tax | $bn | [3.7 d](/filings/0001652044-26-000018.md) | [4.7](/filings/0001652044-25-000043.md) | [3.9](/filings/0001652044-25-000062.md) | [5.4](/filings/0001652044-25-000091.md) | [5.7 d](/filings/0001652044-26-000018.md) | [7.2](/filings/0001652044-26-000048.md) | [5.7](/filings/0001652044-26-000071.md) | [9.0](/filings/0001652044-26-000084.md) | [4.7 d](/filings/0001652044-26-000018.md) | [14.8](/filings/0001652044-26-000048.md) | [26.6](/filings/0001652044-26-000071.md) | [5.9](/filings/0001652044-26-000084.md) |
| Net income | $bn | [20.7 d](/filings/0001652044-26-000018.md) | [23.7](/filings/0001652044-25-000043.md) | [23.6](/filings/0001652044-25-000062.md) | [26.3](/filings/0001652044-25-000091.md) | [26.5 d](/filings/0001652044-26-000018.md) | [34.5](/filings/0001652044-26-000048.md) | [28.2](/filings/0001652044-26-000071.md) | [35.0](/filings/0001652044-26-000084.md) | [34.5 d](/filings/0001652044-26-000018.md) | [62.6](/filings/0001652044-26-000048.md) | [112](/filings/0001652044-26-000071.md) | [26.5](/filings/0001652044-26-000084.md) |
| Diluted EPS | $ per share | not reported | [1.89](/filings/0001652044-25-000043.md) | [1.89](/filings/0001652044-25-000062.md) | [2.12](/filings/0001652044-25-000091.md) | not reported | [2.81](/filings/0001652044-26-000048.md) | [2.31](/filings/0001652044-26-000071.md) | [2.87](/filings/0001652044-26-000084.md) | not reported | [5.11](/filings/0001652044-26-000048.md) | [9.11](/filings/0001652044-26-000071.md) | [2.12](/filings/0001652044-26-000084.md) |
| Basic EPS | $ per share | not reported | [1.91](/filings/0001652044-25-000043.md) | [1.91](/filings/0001652044-25-000062.md) | [2.14](/filings/0001652044-25-000091.md) | not reported | [2.84](/filings/0001652044-26-000048.md) | [2.33](/filings/0001652044-26-000071.md) | [2.89](/filings/0001652044-26-000084.md) | not reported | [5.17](/filings/0001652044-26-000048.md) | [9.23](/filings/0001652044-26-000071.md) | [2.14](/filings/0001652044-26-000084.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [24.0](/filings/0001652044-25-000014.md) | [24.5](/filings/0001652044-24-000053.md) | [27.2](/filings/0001652044-24-000079.md) | [20.0](/filings/0001652044-24-000118.md) | [23.5](/filings/0001652044-26-000018.md) | [23.3](/filings/0001652044-25-000043.md) | [21.0](/filings/0001652044-25-000062.md) | [23.1](/filings/0001652044-25-000091.md) | [30.7](/filings/0001652044-26-000084.md) | [38.1](/filings/0001652044-26-000048.md) | [55.9](/filings/0001652044-26-000071.md) | [56.3](/filings/0001652044-26-000084.md) |
| Current assets | $bn | [172](/filings/0001652044-25-000014.md) | [165](/filings/0001652044-24-000053.md) | [162](/filings/0001652044-24-000079.md) | [158](/filings/0001652044-24-000118.md) | [164](/filings/0001652044-26-000018.md) | [162](/filings/0001652044-25-000043.md) | [166](/filings/0001652044-25-000062.md) | [174](/filings/0001652044-25-000091.md) | [206](/filings/0001652044-26-000084.md) | [214](/filings/0001652044-26-000048.md) | [344](/filings/0001652044-26-000071.md) | [375](/filings/0001652044-26-000084.md) |
| Total assets | $bn | [402](/filings/0001652044-25-000014.md) | [407](/filings/0001652044-24-000053.md) | [415](/filings/0001652044-24-000079.md) | [430](/filings/0001652044-24-000118.md) | [450](/filings/0001652044-26-000018.md) | [475](/filings/0001652044-25-000043.md) | [502](/filings/0001652044-25-000062.md) | [536](/filings/0001652044-25-000091.md) | [595](/filings/0001652044-26-000084.md) | [704](/filings/0001652044-26-000048.md) | [922](/filings/0001652044-26-000071.md) | [1,003](/filings/0001652044-26-000084.md) |
| Current liabilities | $bn | [81.8](/filings/0001652044-25-000014.md) | [77.0](/filings/0001652044-24-000053.md) | [77.9](/filings/0001652044-24-000079.md) | [80.8](/filings/0001652044-24-000118.md) | [89.1](/filings/0001652044-26-000018.md) | [91.7](/filings/0001652044-25-000043.md) | [87.3](/filings/0001652044-25-000062.md) | [99.6](/filings/0001652044-25-000091.md) | [103](/filings/0001652044-26-000084.md) | [111](/filings/0001652044-26-000048.md) | [126](/filings/0001652044-26-000071.md) | [135](/filings/0001652044-26-000084.md) |
| Total liabilities | $bn | [119](/filings/0001652044-25-000014.md) | [115](/filings/0001652044-24-000053.md) | [114](/filings/0001652044-24-000079.md) | [116](/filings/0001652044-24-000118.md) | [125](/filings/0001652044-26-000018.md) | [130](/filings/0001652044-25-000043.md) | [139](/filings/0001652044-25-000062.md) | [150](/filings/0001652044-25-000091.md) | [180](/filings/0001652044-26-000084.md) | [225](/filings/0001652044-26-000048.md) | [282](/filings/0001652044-26-000071.md) | [326](/filings/0001652044-26-000084.md) |
| Long-term debt | $bn | [11.9](/filings/0001652044-25-000014.md) | not reported | not reported | not reported | [10.9](/filings/0001652044-26-000018.md) | [10.9](/filings/0001652044-25-000043.md) | [23.6](/filings/0001652044-25-000062.md) | [21.6](/filings/0001652044-25-000091.md) | [46.5](/filings/0001652044-26-000084.md) | [77.5](/filings/0001652044-26-000048.md) | [98.2](/filings/0001652044-26-000071.md) | [125](/filings/0001652044-26-000084.md) |
| Current portion of debt | $bn | [1.0](/filings/0001652044-25-000014.md) | [0.0](/filings/0001652044-24-000053.md) | [0.0](/filings/0001652044-24-000079.md) | [1.0](/filings/0001652044-24-000118.md) | [1.0](/filings/0001652044-26-000018.md) | [1.0](/filings/0001652044-25-000043.md) | [1.0](/filings/0001652044-25-000062.md) | [2.0](/filings/0001652044-25-000091.md) | [2.0](/filings/0001652044-26-000084.md) | [2.0](/filings/0001652044-26-000048.md) | [2.0](/filings/0001652044-26-000071.md) | [1.0](/filings/0001652044-26-000084.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001652044-25-000014.md) | [0.0](/filings/0001652044-24-000053.md) | [0.0](/filings/0001652044-24-000079.md) | [1.0](/filings/0001652044-24-000118.md) | [2.3](/filings/0001652044-26-000018.md) | [2.5](/filings/0001652044-25-000043.md) | [3.0](/filings/0001652044-25-000062.md) | [3.0](/filings/0001652044-25-000091.md) | [0.0](/filings/0001652044-26-000084.md) | not reported | [0.0](/filings/0001652044-26-000071.md) | [0.0](/filings/0001652044-26-000084.md) |
| Shareholders' equity | $bn | [283](/filings/0001652044-26-000018.md) | [293](/filings/0001652044-25-000062.md) | [301](/filings/0001652044-25-000091.md) | [314](/filings/0001652044-25-000091.md) | [325](/filings/0001652044-26-000084.md) | [345](/filings/0001652044-26-000071.md) | [363](/filings/0001652044-26-000084.md) | [387](/filings/0001652044-26-000084.md) | [415](/filings/0001652044-26-000084.md) | [479](/filings/0001652044-26-000071.md) | [640](/filings/0001652044-26-000084.md) | [678](/filings/0001652044-26-000084.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [18.9 d](/filings/0001652044-26-000018.md) | [28.8](/filings/0001652044-25-000043.md) | [26.6 d](/filings/0001652044-25-000062.md) | [30.7 d](/filings/0001652044-25-000091.md) | [39.1 d](/filings/0001652044-26-000018.md) | [36.2](/filings/0001652044-26-000048.md) | [27.7 d](/filings/0001652044-26-000071.md) | [48.4 d](/filings/0001652044-26-000084.md) | [52.4 d](/filings/0001652044-26-000018.md) | [45.8](/filings/0001652044-26-000048.md) | [39.1 d](/filings/0001652044-26-000071.md) | [42.3 d](/filings/0001652044-26-000084.md) |
| Capital expenditure | $bn | [11.0 d](/filings/0001652044-26-000018.md) | [12.0](/filings/0001652044-25-000043.md) | [13.2 d](/filings/0001652044-25-000062.md) | [13.1 d](/filings/0001652044-25-000091.md) | [14.3 d](/filings/0001652044-26-000018.md) | [17.2](/filings/0001652044-26-000048.md) | [22.4 d](/filings/0001652044-26-000071.md) | [24.0 d](/filings/0001652044-26-000084.md) | [27.9 d](/filings/0001652044-26-000018.md) | [35.7](/filings/0001652044-26-000048.md) | [44.9 d](/filings/0001652044-26-000071.md) | [51.4 d](/filings/0001652044-26-000084.md) |
| Dividends paid | $bn | [0.0 d](/filings/0001652044-26-000018.md) | [0.0](/filings/0001652044-25-000043.md) | [2.5 d](/filings/0001652044-25-000062.md) | [2.5 d](/filings/0001652044-25-000091.md) | [2.4 d](/filings/0001652044-26-000018.md) | [2.4](/filings/0001652044-26-000048.md) | [2.5 d](/filings/0001652044-25-000062.md) | [2.5 d](/filings/0001652044-25-000091.md) | [2.5 d](/filings/0001652044-26-000018.md) | [2.5](/filings/0001652044-26-000048.md) | not reported | not reported |
| Share repurchases | $bn | [16.2 d](/filings/0001652044-26-000018.md) | [15.7](/filings/0001652044-25-000043.md) | [15.7 d](/filings/0001652044-25-000062.md) | [15.3 d](/filings/0001652044-25-000091.md) | [15.6 d](/filings/0001652044-26-000018.md) | [15.1](/filings/0001652044-26-000048.md) | [13.2 d](/filings/0001652044-26-000071.md) | [11.5 d](/filings/0001652044-26-000084.md) | [5.9 d](/filings/0001652044-26-000018.md) | [0.0](/filings/0001652044-26-000048.md) | [0.0 d](/filings/0001652044-26-000071.md) | [0.0 d](/filings/0001652044-26-000084.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [12.8](/filings/0001652044-24-000079.md) | [12.7](/filings/0001652044-24-000118.md) | [12.5](/filings/0001652044-25-000043.md) | [12.5](/filings/0001652044-25-000062.md) | [12.4](/filings/0001652044-25-000091.md) | [12.3](/filings/0001652044-26-000048.md) | [12.2](/filings/0001652044-26-000071.md) | [12.2](/filings/0001652044-26-000084.md) | [12.2](/filings/0001652044-26-000048.md) | [12.3](/filings/0001652044-26-000071.md) | [12.4](/filings/0001652044-26-000084.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 06:10 ET. No prices; not investment advice.